Sinclair Pharma plc is an international specialty pharmaceutical company.  It has a growing sales and marketing operation that is already present in France, Italy, the UK, Spain and Portgual, and a complementary network of marketing partners in 82 countries.

Sinclair has proven expertise in acquiring or developing commercially attractive and undervalued products, registering these products and bringing them to market in a short time frame.  The company focuses on niche therapeutic areas and its current portfolio includes products in dermatology and oral health.

The company is experiencing strong sales growth, particularly for its flagship products Atopiclair (eczema/atopic dermatitis), Decapinol (gingivitis/gum disease) and Aloclair (mouth ulcers).

The Sinclair portfolio includes 20 registered products in the EU and 11 in the US.